Systemic Lupus Clinical Trials in Hangzhou, Zhejiang
15 recruitingHangzhou, Zhejiang, China
Showing 1–15 of 15 trials
Recruiting
Early Phase 1
CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease
IgA Nephropathy (IgAN)Autoimmune DiseasesSystemic Sclerosis (SSc)+3 more
The Children's Hospital of Zhejiang University School of Medicine15 enrolled1 locationNCT07586267
Recruiting
Early Phase 1
Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
IgA Nephropathy (IgAN)Autoimmune DiseasesSystemic Sclerosis (SSc)+3 more
The Children's Hospital of Zhejiang University School of Medicine15 enrolled1 locationNCT07507201
Recruiting
Early Phase 1
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases
Systemic Lupus Erythematosus (SLE)Rheumatic DiseasesPediatric Rheumatological Condition (i.e., Arthritis, SLE, Kawasaki's Disaese)+1 more
The Children's Hospital of Zhejiang University School of Medicine36 enrolled1 locationNCT07490041
Recruiting
Phase 3
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
AbbVie1,000 enrolled369 locationsNCT05843643
Recruiting
Early Phase 1
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Moderate to Severe Active SLE Clinical Research
Systemic Lupus Erythematosus
Zhejiang University36 enrolled1 locationNCT06711146
Recruiting
Phase 1
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
IgA Nephropathy (IgAN)Autoimmune DiseasesSystemic Sclerosis (SSc)+3 more
The Children's Hospital of Zhejiang University School of Medicine15 enrolled1 locationNCT07305116
Recruiting
Not Applicable
Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases
Systemic Lupus ErythematosusSjogren's SyndromeSystemic Sclerosis (SSc)+3 more
Second Affiliated Hospital, School of Medicine, Zhejiang University15 enrolled1 locationNCT06614270
Recruiting
Phase 1
Clinical Trial of CD19 Targeted CAR-T Cell in Refractory Adult SLE
Systemic Lupus Erythematosus (SLE)Refractory
Chongqing Precision Biotech Co., Ltd12 enrolled2 locationsNCT06892145
Recruiting
Early Phase 1
Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease
Autoimmune DiseasesSystemic Lupus ErthematosusMulti-Drug Resistant Nephrotic Syndrome+1 more
The Children's Hospital of Zhejiang University School of Medicine36 enrolled1 locationNCT06792799
Recruiting
Phase 1
Blinatumomab in Refractory Active Childhood Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)BlinatumomabChildren
Mao Jianhua6 enrolled2 locationsNCT06789107
Recruiting
Phase 1
Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE
Systemic Lupus Erythematosus
The Children's Hospital of Zhejiang University School of Medicine18 enrolled1 locationNCT07233642
Recruiting
Early Phase 1
UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Zhejiang University18 enrolled1 locationNCT06920433
Recruiting
Phase 1
Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE
CAR-T Cell TherapySystemic Lupus ErythematosusBCMA
The Children's Hospital of Zhejiang University School of Medicine18 enrolled1 locationNCT06934447
Recruiting
Phase 1
Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
The Children's Hospital of Zhejiang University School of Medicine18 enrolled1 locationNCT06691152
Recruiting
Not Applicable
Universal CAR-T Cells (BRL-301) in Refractory Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)
Bioray Laboratories12 enrolled1 locationNCT05988216